Use drugs better. Self-paced video CE courses for counselors and other helping professionals. Practical skills for positive drug-use experiences. Course below.
Use drugs better.
Beyond Harm Reduction Buzzwords teaches practical drug-use skills for counselors and other helping professionals.
Self-paced video-based continuing education. 2 CE hours. $39.
Take the course: https://t.co/FScOKeybbl
There are a couple of investigations on the sale but I don't anticipate much coming from them. Hard not to go full conspiracy theorist on this one but the product delays (oh look new innovations right after the deal!); "data migration/tech debt" make sense; as do those ridiculous block sales RIGHT when the share price was improving about a year ago. The plan has always been to sell; but the price was ridiculous; and if its not then Herd should take the same share price too. Now would be a good time for a shareholder aligned hostile bidder but it seems unlikely.
agree with both you and @hamids on this one. This is one of my only winning trades that leaves a bad taste in my mouth. The deal seemed off. Probably never know the actual behind the scenes on it but the value on $BMBL was deep and congrats to the buyers, I don't blame them; but they are now going to harvest the upside while shareholders subsidized the wishy washy floundering over the last 2 years. I was this for a multibagger as the setup was really nice.
Also, I learned a lot on this trade; namely keep being patient, make large bets; but more importantly be wary of dumbass share structures. That was really what allowed this 6.05 nonsense to happen. I broke that last rule.
I'd like to see a competing offer and I am still positioned to gain from one though I doubt its coming. Took all my profits other than the OTM Leaps that are staying OTM because of said deal but still a nicely profitable trade without them. Oh well, back to the waiting and researching game for a while.
I anticipated 8-11 on the buyout price; and 6.05 is profit but its a steal and the board knows it. they don't care about shareholders, never have. Their shares were free.
Still positioned with some leaps to the upside for a possible hostile bid but it seems unlikely with that dumb ass share structure. Other deals will come along but this was the most assymetric one I had seen in a while
Today we announced an agreement to acquire Bumble.
Over the past six months, we’ve looked at hundreds of companies, asking which businesses would become more valuable as AI advances.
Bumble stood out.
As intelligence becomes more abundant, we believe connecting with the right person and forming meaningful relationships will become even more precious. And frontier technology can help more people find and build those relationships.
Our purpose at Ithaca is to apply frontier technology to things that matter. We acquire enduring businesses, transform them with technology, and hold for the long term. We focus on businesses not only for their financial potential but their ability to enrich lives.
Whitney and her team have built something extraordinary. Millions of relationships began on Bumble, and we’re honored to help take it into its next era. Together we intend to build the best company in the world for helping people find each other.
Let’s get to work.
Today, we’re sharing a meaningful moment in Bumble’s story: we have entered into an agreement to be acquired by Ithaca Holdings.
This is a new chapter, but not a new mission. Bumble will continue to be driven by the same purpose that inspired us from the beginning.
Find out more here: https://t.co/5oq4qVPucS
meh. There is still a lot to play out; no one actually knows deal details and sale price nor how its valued, and if management has shown me anything its that they can fumble nearly any opportunity. Congrats to @GuptaRK22@johnwhegeman for actually keeping a straight face during the deal.
Tomorrow belongs in the plan. Help clients think through recovery time and next-day responsibilities when planning a drug-use experience.
Learn how in Beyond Harm Reduction Buzzwords: $39, self-paced video continuing education.
Use drugs better.
https://t.co/mHcjQdziAV
Psychedelics show promise for depression and anxiety. Federal support is growing, but drugs are advancing at different speeds. Here’s what to know. https://t.co/pk3oVd8F4i
@LickingHealth A useful training exercise: practice asking, “What are you hoping to get from the experience?” Then ask what a good experience would look like in their own words. That gives the conversation a concrete goal to work with.
@TarekAntaki Next earnings report is important for my thesis. Will user numbers hold on a QoQ basis? I’m bullish but hearing an actual plan from them would be nice. Is there a plan? “Focus on quality” is a nice start but next steps have been vague at best; a scattered mess is more accurate.